Page 7 - Expanded Access News Today

Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvementsPhase...

Data Bridge Market Researchs latest report, "Self-injections Market" provides a thorough analysis of growth strategies, drivers, opportunities, key segments,

Company on track to complete enrollment in ongoing pivotal Phase 3 global study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 by year end 2023 ... | May 15, 2023

NEW YORK, May 3, 2023 /PRNewswire/ -- As per Zion Market Research study, The global clinical trials market size is set for rapid growth over the forecast period. In terms of revenue, the global

Read the latest Texas Coronavirus headlines, all in one place, on NewsNow: the one-stop shop for news

SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) a...

Recognized standard clinical outcome assessment. In March: Tiziana announced a publication in the preeminent1 journal, Proceedings of the National Academy of Sciences , that... | April 26, 2023

NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel

21.04.2023 - Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, ...

Visiongain has published a new report entitled Decentralised Clinical Trials 2023-2033.   Forecasts by Indication (Oncology, Cardiovascular,...